Comparison with Standard Treatments
Studies comparing BPC-157 to becaplermin (the active ingredient in Regranex, an FDA-approved treatment for diabetic foot ulcers) found BPC-157 produced superior results in several parameters. BPC-157 stimulate…
Comparison
bpc 157 for skin: Topic comparisons
Approved comparison material connected to this topic.
3 total recordsSide-by-side reading
Comparison records
Source comparisons are presented without a generated winner.
Read comparison →
The Research Evidence Gap: Animal Models vs Human Clinical Data
Every published study demonstrating dermal wound healing effects of using BPC-157 for skin health research evidence has been conducted in rodent models. Primarily Wistar rats and C57BL/6 mice. The standard pro…
BPC-157 Skin Health Research: Comparison of Study Protocols
Rat excisional wound (Zagreb, 2011) 10 µg/kg daily Intraperitoneal injection Re-epithelialization rate 37% faster closure by day 7 VEGF upregulation, increased capillary density Robust preclinical evidence but…